









Markets
/
Stocks
/
nasdaq-avbp
/

Arrivent Biopharma Inc

AVBP

21.970USD

-0.320-1.44%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

897.53MMarket Cap

LossP/E TTM



Arrivent Biopharma Inc

21.970

-0.320-1.44%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Arrivent Biopharma Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

Total equity

Cash, cash equivalents and short-term investments

6.16%300.27M

-21.09%235.69M

-44.52%176.08M

45.53%218.86M

70.03%282.86M

63.36%298.67M

--317.39M

--150.39M

--166.36M

--182.83M

- Cash and cash equivalents

-60.17%112.67M

-62.24%112.77M

-84.29%49.87M

-50.60%74.29M

100.10%282.86M

89.23%298.67M

--317.39M

--150.39M

--141.36M

--157.83M

-Short-term investments

--187.59M

--122.92M

--126.21M

--144.57M

----

--25.00M

Receivables

1.00%505.00K

-32.67%505.00K

-42.29%505.00K

-34.30%500.00K

-54.09%500.00K

190.70%750.00K

--875.00K

--761.00K

--1.09M

--258.00K

-Other receivables

----

--456.00K

----

Prepaid expenses

-85.09%102.00K

-72.92%130.00K

-27.68%303.00K

-2.92%233.00K

406.67%684.00K

91.24%480.00K

--419.00K

--240.00K

--135.00K

--251.00K

Other current assets

143.39%20.34M

60.56%13.83M

1.22%8.90M

-13.93%7.38M

-32.57%8.36M

-43.87%8.61M

--8.79M

--8.58M

--12.40M

--15.34M

Total current assets

9.86%321.22M

-18.92%250.15M

-43.27%185.78M

41.89%226.98M

62.46%292.40M

55.28%308.51M

--327.48M

--159.97M

--179.98M

--198.69M

Non-current assets

Net Fixed Assets

-73.80%49.00K

-61.19%85.00K

-52.00%120.00K

-47.08%154.00K

325.00%187.00K

188.16%219.00K

--250.00K

--291.00K

--44.00K

--76.00K

Other non-current assets

42.86%180.00K

283.20%479.00K

62.96%176.00K

-95.56%126.00K

-93.58%126.00K

52.44%125.00K

--108.00K

--2.84M

--1.96M

--82.00K

Total non-current assets

1605.11%5.34M

5527.03%19.36M

8198.88%29.71M

1432.36%47.96M

-84.40%313.00K

117.72%344.00K

--358.00K

--3.13M

--2.01M

--158.00K

Total assets

11.56%326.56M

-12.74%269.51M

-34.27%215.50M

68.57%274.94M

60.84%292.71M

55.33%308.86M

--327.84M

--163.10M

--181.99M

--198.84M

Liabilities

Current liabilities

-Other payables

---105.00K

--0.00

----

Accrued expenses

50.29%15.57M

90.29%15.48M

47.44%8.45M

91.74%13.33M

97.77%10.36M

29.54%8.13M

--5.73M

--6.95M

--5.24M

--6.28M

Other current liabilities

---105.00K

--0.00

----

Total current liabilities

42.18%21.56M

62.31%19.64M

29.83%12.95M

48.61%17.27M

50.12%15.16M

-5.58%12.10M

--9.98M

--11.62M

--10.10M

--12.81M

Non-current liabilities

Long-term debt and lease liabilities

-100.00%0.00

-92.09%14.00K

--56.00K

--98.00K

--138.00K

--177.00K

--0.00

-Long-term lease liabilities

----

-100.00%0.00

-92.09%14.00K

--56.00K

--98.00K

--138.00K

--177.00K

--0.00

Other non-current liabilities

--0.00

----

Total non-current liabilities

----

-100.00%0.00

-92.09%14.00K

--56.00K

--98.00K

--138.00K

--177.00K

--0.00

Total liabilities

41.66%21.56M

61.00%19.64M

28.06%12.95M

46.50%17.29M

50.67%15.22M

-4.82%12.20M

--10.12M

--11.80M

--10.10M

--12.81M

Shareholders' equity

Common equity

36.09%673.89M

18.27%584.01M

2.49%505.28M

10566.34%496.20M

11820.87%495.19M

12922.02%493.80M

--492.99M

--4.65M

--4.15M

--3.79M

Preferred equity

----

--304.49M

Retained earnings

-69.54%-369.10M

-69.49%-334.12M

-72.72%-302.72M

-50.99%-238.33M

-59.31%-217.70M

-61.26%-197.14M

---175.26M

---157.84M

---136.65M

---122.25M

Capital reserves

36.09%673.88M

18.27%584.00M

2.49%505.27M

10566.27%496.19M

11820.80%495.19M

12935.69%493.79M

--492.98M

--4.65M

--4.15M

--3.79M

Gains losses not affecting retained earnings

--206.00K

---18.00K

---17.00K

---211.00K

----

Total equity

9.91%305.00M

-15.77%249.87M

-36.25%202.54M

70.30%257.65M

61.44%277.49M

59.47%296.66M

--317.72M

--151.30M

--171.89M

--186.03M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

